Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

PRAN 1.15
price chart
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Expect Success In ...
Prana is an Australian biotech with a potential treatment for Alzheimer's disease. Potential future revenues of at least $5 billion, but market cap is only $295 million.
Today's Top Biotech Stories: Prana, Actavis, Forest Labs, and Novartis  Motley Fool
Prana Biotechnology Limited releases trial results: But is it set for ...  Ninemsn
Related articles »  
Prana Biotechnology Limited Short Interest Down 40.3% in May (PRAN)
Receive News & Ratings for Prana Biotechnology Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology Limited and related companies with MarketBeat.com's FREE ...
Prana Biotechnology Stock Surges On Approval
Prana Biotechnology Limited (ADR) (PRAN) is up over 30% during trading today on the back of orphan drug designation for its drug PBT2.
Prana Biotechnology Limited leaps on potential breakthrough: Should you buy?  Motley Fool Australia
Prana Biotechnology's PBT2 receives FDA Orphan Drug designation  Proactive Investors Australia
Related articles »  
Should You Invest In Prana Biotechnology Limited (PRAN), IsoRay, Inc.(ISR ...
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) lost $1.09 to finish the day at a closing price of $1.09. The 33.54% decline in value came on a day when the stock traded for as little as $1.07, a new 52 week low for Melbourne-based biotechnology ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Falls On Fears
As with other small capped development stage bio tech firms, Australia based Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) too is heavily vulnerable to analyst and trade guru commentary on the prospects of the development stage drugs which firms ...
Prana Biotechnology (PRAN) Stock Declines; Summer Street Not Impressed with ...  StreetInsider.com (subscription)
Related articles »  
BEST STOCKS TODAY: AVEO Pharmaceuticals, Inc., Prana Biotechnology ...
OTCFire.com provides it's members with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, and hidden stocks traded on the NASDAQ, NYSE, AMEX, and OTC Markets with the potential of fast gains.
Prana Biotechnology Limited responds to ASX speeding ticket: What you need ...  Motley Fool Australia
Traders Buzz: Prima Biomed Ltd. (NASDAQ:PBMD), Prana Biotechnology ...
... investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Prima Biomed Ltd.
Short Interest in Prana Biotechnology Limited Declines By 40.3% (PRAN)
Receive News & Ratings for Prana Biotechnology Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology Limited and related companies with MarketBeat.com's FREE ...
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.